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After publication of the original article [1], it came to the
authors’ attention that there is an error in the originally-
published version of Fig. 2. The labelling of the x-axis for
Fig. 2 is not correct. The last two values of the x-axis
should read: “5-11” instead of “5”, and “12+” instead of “6”.
The correct version of Fig. 2 is published in this erratum.
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Fig. 2 Measured day 7 lumefantrine concentrations in patients given
supervised treatment with the recommended six-dose artemether-
lumefantrine regimen, by age and nutrition status. Concentrations
are dose-adjusted and scaled for a total dose of 72 mg/kg (after
excluding patients with quantifiable lumefantrine concentrations
pre-treatment). Outside values are not shown
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